Clinical trialObsActive not recruiting
Safety and Efficacy of EUS-RFA in the Treatment of Pancreatic Lesions: A Prospective Registry
Safety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic Lesions: A Prospective Registry
- Outcome
- Ongoing
- Phase
- Obs
- Status
- Active not recruiting
- Study type
- Observational
- Start
- 30 October 2018
- Expected end
- 1 July 2028
- Enrollment
- 100 participants
- Sites
- 1
- Primary outcomes
- Technical Success of EUS-RFA Defined as Complete Ablation of Target Pancreatic Lesions on Imaging
- Sponsor
- Other
- Results posted
- No
- Last update
- 12 May 2026
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try